Narrow Search
Last searches

Results for *

Displaying results 1 to 4 of 4.

  1. The WTO TRIPS decision on COVID-19 vaccines
    what is needed to implement it?
    Published: [2022]
    Publisher:  South Centre, Geneva, Switzerland

    The 12th WTO Ministerial Conference adopted a Ministerial Decision on the TRIPS Agreement on 17 June 2022. This partially concluded almost two years of protracted discussions in response to a proposal by India and South Africa for a waiver from... more

    Access:
    Verlag (kostenfrei)
    Verlag (kostenfrei)
    Resolving-System (kostenfrei)
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    DS 751
    No inter-library loan

     

    The 12th WTO Ministerial Conference adopted a Ministerial Decision on the TRIPS Agreement on 17 June 2022. This partially concluded almost two years of protracted discussions in response to a proposal by India and South Africa for a waiver from certain obligations under the TRIPS Agreement for health products and technologies for the prevention, treatment and containment of COVID-19. The adopted Decision only waives the obligation under article 31 (f) of the TRIPS Agreement. Developing country WTO members are now allowed to export any proportion of vaccines, including ingredients and processes, necessary for the COVID-19 pandemic that are manufactured under a compulsory license or government use authorization to other developing countries. It also contains some clarifications of relevant TRIPS provisions, while introducing a number of conditionalities that are not present in the TRIPS Agreement. This paper examines the object and scope of the Decision, the requirements established for its use, and the required actions to be taken by WTO members to implement it.

     

    Export to reference management software   RIS file
      BibTeX file
    Source: Union catalogues
    Language: English
    Media type: Book
    Format: Online
    Other identifier:
    hdl: 10419/278266
    Series: Research paper / South Centre ; 169 (8 November 2022)
    Subjects: Compulsory Licenses; COVID-19; Diagnostics; Dispute Settlement; Doha Declaration on the TRIPS Agreement and Public Health; Flexibilities; Government Use; MC12; Pandemic; Parallel Importation; Test Data; Therapeutics; TRIPS; TRIPS Agreement; TRIPS Flexibilities; TRIPS Waiver; Vaccines; Voluntary License; World Trade Organization (WTO); WTO TRIPS Decision on COVID-19 Vaccines
    Scope: 1 Online-Ressource (circa 36 Seiten)
  2. Guide for the granting of compulsory licenses and government use of pharmaceutical patents
    Published: 2020
    Publisher:  South Centre, Geneva

    Access:
    Verlag (kostenfrei)
    Verlag (kostenfrei)
    Resolving-System (kostenfrei)
    Universitätsbibliothek Braunschweig
    No inter-library loan
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    DS 751
    No inter-library loan
    Export to reference management software   RIS file
      BibTeX file
  3. Guía para la concesión de licencias obligatorias y uso gubernamental de patentes farmacéuticas
    Published: 2020
    Publisher:  South Centre, Ginebra

    Access:
    Verlag (kostenfrei)
    Verlag (kostenfrei)
    Resolving-System (kostenfrei)
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    DS 751
    No inter-library loan
    Export to reference management software   RIS file
      BibTeX file
  4. Designing pro-health competition policies in developing countries